Literature DB >> 2547681

Impaired insulin-like growth factor I-mediated stimulation of glucose incorporation into glycogen in vivo in the ob/ob mouse.

M A Cascieri1, E E Slater, P P Vicario, B G Green, M L Bayne, R Saperstein.   

Abstract

The ability of insulin to modulate glucose metabolism is impaired in insulin resistant ob/ob mice. It has been shown that insulin-like growth factor I stimulates the uptake and metabolism of glucose in muscle through the insulin-like growth factor receptor not the insulin receptor. Thus, we have compared the abilities of insulin-like growth factor I and insulin to stimulate the in vivo incorporation of [14C]-glucose into glycogen in the diaphragm of ob/ob mice and their lean littermates. The animals used in these studies were 12-14 weeks old and the serum insulin levels of the ob/ob mice were 16-fold higher than in their lean littermates. There were no differences in the serum levels of glucose or insulin-like growth factor I. Both insulin and insulin-like growth factor I stimulate the incorporation of [14C]-glucose into glycogen in lean mice. Significant stimulation occurs at doses as low as 1 micrograms/kg of either peptide. The effective doses of insulin and insulin-like growth factor I are quite similar, which indicates that the effect of insulin-like growth factor I is mediated by the insulin-like growth factor receptor and not the insulin receptor. In contrast, greater than 100 micrograms/kg of insulin-like growth factor I is required to stimulate [14C]-glucose incorporation into glycogen in the diaphragm of ob/ob mice. Thus, ob/ob mice are resistant to the action of both insulin and insulin-like growth factor I.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2547681     DOI: 10.1007/BF00277256

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  36 in total

1.  Effects and binding of insulin-like growth factor I in the isolated soleus muscle of lean and obese mice: comparison with insulin.

Authors:  C Poggi; Y Le Marchand-Brustel; J Zapf; E R Froesch; P Freychet
Journal:  Endocrinology       Date:  1979-09       Impact factor: 4.736

2.  Defective insulin receptor tyrosine kinase in human skeletal muscle in obesity and type 2 (non-insulin-dependent) diabetes mellitus.

Authors:  P Arner; T Pollare; H Lithell; J N Livingston
Journal:  Diabetologia       Date:  1987-06       Impact factor: 10.122

3.  Estimation of somatomedin-C levels in normals and patients with pituitary disease by radioimmunoassay.

Authors:  R W Furlanetto; L E Underwood; J J Van Wyk; A J D'Ercole
Journal:  J Clin Invest       Date:  1977-09       Impact factor: 14.808

4.  Insulin and nonsuppressible insulin-like activity (NSILA-S) stimulate the same glucose transport system via two separate receptors in rat heart.

Authors:  C Meuli; E R Froesch
Journal:  Biochem Biophys Res Commun       Date:  1977-04-11       Impact factor: 3.575

5.  Insulin-receptor interaction in the obese-hyperglycemic mouse. A model of insulin resistance.

Authors:  C R Kahn; D M Neville; J Roth
Journal:  J Biol Chem       Date:  1973-01-10       Impact factor: 5.157

6.  Coated charcoal immunoassay of insulin.

Authors:  V Herbert; K S Lau; C W Gottlieb; S J Bleicher
Journal:  J Clin Endocrinol Metab       Date:  1965-10       Impact factor: 5.958

7.  The subunit structures of two distinct receptors for insulin-like growth factors I and II and their relationship to the insulin receptor.

Authors:  J Massagué; M P Czech
Journal:  J Biol Chem       Date:  1982-05-10       Impact factor: 5.157

8.  Expression, purification and characterization of recombinant human insulin-like growth factor I in yeast.

Authors:  M L Bayne; J Applebaum; G G Chicchi; N S Hayes; B G Green; M A Cascieri
Journal:  Gene       Date:  1988-06-30       Impact factor: 3.688

9.  Insulin receptor tyrosine kinase activity is unaltered in ob/ob and db/db mouse skeletal muscle membranes.

Authors:  P Vicario; E J Brady; E E Slater; R Saperstein
Journal:  Life Sci       Date:  1987-09-07       Impact factor: 5.037

10.  Serum half-life and biological activity of mutants of human insulin-like growth factor I which do not bind to serum binding proteins.

Authors:  M A Cascieri; R Saperstein; N S Hayes; B G Green; G G Chicchi; J Applebaum; M L Bayne
Journal:  Endocrinology       Date:  1988-07       Impact factor: 4.736

View more
  1 in total

1.  Evidence for a circulating islet cell growth factor in insulin-resistant states.

Authors:  S N Flier; R N Kulkarni; C R Kahn
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-12       Impact factor: 11.205

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.